High-mobility group box 1 in Parkinson's disease: from pathogenesis to therapeutic approaches
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High-mobility group box 1 in Parkinson's disease: from pathogenesis to therapeutic approaches
Authors
Keywords
-
Journal
JOURNAL OF NEUROCHEMISTRY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-04-20
DOI
10.1111/jnc.14450
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Role of High-Mobility Group Box-1 and Its Crosstalk with Microbiome in Rheumatoid Arthritis
- (2017) Federico Biscetti et al. MEDIATORS OF INFLAMMATION
- Quantitative estimation of motor fluctuations in Parkinson's disease
- (2017) Roberta Bonomo et al. PARKINSONISM & RELATED DISORDERS
- Toxicological Effects of Glycyrrhiza glabra (Licorice): A Review
- (2017) Somayeh Nazari et al. PHYTOTHERAPY RESEARCH
- HMGB1 Mediates Autophagy Dysfunction via Perturbing Beclin1-Vps34 Complex in Dopaminergic Cell Model
- (2017) Jinsha Huang et al. Frontiers in Molecular Neuroscience
- Parkinsons disease in the older patient
- (2016) S. J. Lewis et al. CLINICAL MEDICINE
- Dichotomous Life of DNA Binding High Mobility Group Box1 Protein in Human Health and Disease
- (2016) Neelam Lohani et al. CURRENT PROTEIN & PEPTIDE SCIENCE
- Beclin1 and HMGB1 ameliorate the α-synuclein-mediated autophagy inhibition in PC12 cells
- (2016) Kaihua Wang et al. Diagnostic Pathology
- Anti-high mobility group box 1 antibody exerts neuroprotection in a rat model of Parkinson's disease
- (2016) Tatsuya Sasaki et al. EXPERIMENTAL NEUROLOGY
- A novel high mobility group box 1 neutralizing chimeric antibody attenuates drug-induced liver injury and postinjury inflammation in mice
- (2016) Peter Lundbäck et al. HEPATOLOGY
- Emerging role of HMGB1 in lung diseases: friend or foe
- (2016) Junying Ding et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- In-vivo evidence that high mobility group box 1 exerts deleterious effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model and Parkinson's disease which can be attenuated by glycyrrhizin
- (2016) Matteo Santoro et al. NEUROBIOLOGY OF DISEASE
- Immunogenicity assessment of monoclonal antibody products: A simulated case study correlating antibody induction with clinical outcomes
- (2015) Ivana Knezevic et al. BIOLOGICALS
- The Roles of PINK1, Parkin, and Mitochondrial Fidelity in Parkinson’s Disease
- (2015) Alicia M. Pickrell et al. NEURON
- Autophagy modulates SNCA/α-synuclein release, thereby generating a hostile microenvironment
- (2014) Anne-Maria Poehler et al. Autophagy
- HMGB1 is involved in autophagy inhibition caused by SNCA/α-synuclein overexpression
- (2013) Ju-Xian Song et al. Autophagy
- Cellular and Molecular Mediators of Neuroinflammation in the Pathogenesis of Parkinson’s Disease
- (2013) Sandeep Vasant More et al. MEDIATORS OF INFLAMMATION
- Elevated serum autoantibody against high mobility group box 1 as a potent surrogate biomarker for amyotrophic lateral sclerosis
- (2013) Chi-Shin Hwang et al. NEUROBIOLOGY OF DISEASE
- Mitochondrial dysfunction and oxidative stress in Parkinson's disease
- (2013) Sudhakar Raja Subramaniam et al. PROGRESS IN NEUROBIOLOGY
- Protein degradation pathways in Parkinson’s disease: curse or blessing
- (2012) Darius Ebrahimi-Fakhari et al. ACTA NEUROPATHOLOGICA
- Anti-high mobility group box-1 antibody therapy for traumatic brain injury
- (2012) Yu Okuma et al. ANNALS OF NEUROLOGY
- Toll-Like Receptor 4 Promotes α-Synuclein Clearance and Survival of Nigral Dopaminergic Neurons
- (2011) Nadia Stefanova et al. AMERICAN JOURNAL OF PATHOLOGY
- HMGB1 Is a Therapeutic Target for Sterile Inflammation and Infection
- (2011) Ulf Andersson et al. Annual Review of Immunology
- High Mobility Group Box 1 (HMGB1) Activates an Autophagic Response to Oxidative Stress
- (2011) Daolin Tang et al. ANTIOXIDANTS & REDOX SIGNALING
- High-Mobility Group Box 1 Is Essential for Mitochondrial Quality Control
- (2011) Daolin Tang et al. Cell Metabolism
- HMGB1 Acts on Microglia Mac1 to Mediate Chronic Neuroinflammation That Drives Progressive Neurodegeneration
- (2011) H.-M. Gao et al. JOURNAL OF NEUROSCIENCE
- High mobility group box protein 1 in complex with lipopolysaccharide or IL-1 promotes an increased inflammatory phenotype in synovial fibroblasts
- (2011) Heidi Wähämaa et al. ARTHRITIS RESEARCH & THERAPY
- Endogenous HMGB1 regulates autophagy
- (2010) Daolin Tang et al. JOURNAL OF CELL BIOLOGY
- The safety and side effects of monoclonal antibodies
- (2010) Trevor T. Hansel et al. NATURE REVIEWS DRUG DISCOVERY
- JNK inhibitor protects dopaminergic neurons by reducing COX-2 expression in the MPTP mouse model of subacute Parkinson's disease
- (2009) Yongsheng Wang et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease
- (2008) T. Pan et al. BRAIN
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started